Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sequencio is a specialized genomic data management and analysis company that provides a cloud-based platform for researchers, clinicians, and pharmaceutical companies. The company's core technology enables the secure storage, processing, and interpretation of large-scale genomic datasets, facilitating precision medicine and drug discovery efforts. By offering tools for variant calling, annotation, and clinical reporting, Sequencio aims to bridge the gap between raw sequencing data and actionable medical insights. The platform is designed to be scalable and compliant with international data privacy standards, supporting collaborative research across global institutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sequencio Therapeutics.